Infliximab therapy leads to clinical and radiographic benefits in early rheumatoid arthritis patients receiving optimum methotrexate dose

Bathon, J.;Devogelaer, Jean-Pierre;Kalden, JR;Shiff, M;Clair, EWS;et.al.
(2004) Annual European Congress of Rheumatology (EULAR 2004) — Location: Berlin (Germany) (9.June.2004)

Files

No attached file found for this publication.

Details

Authors
  • Bathon, J.
    Author
  • Devogelaer, Jean-PierreUCLouvain
    Author
  • Kalden, JR
    Author
  • Shiff, M
    Author
  • Clair, EWS
    Author
Show more
Affiliations

Citations

Bathon, J., Devogelaer, J.-P., Kalden, J., Shiff, M., Emery, P., Maini, R., van der Heijde, D., Keystone, E., Baker, D., Patel, K., Han, J., Smolen, J., & Clair, E. (2004). Infliximab therapy leads to clinical and radiographic benefits in early rheumatoid arthritis patients receiving optimum methotrexate dose. Annals of the Rheumatic Diseases, 63, 293. https://hdl.handle.net/2078.5/140746 (Original work published 2004)